Net profit of Morepen Laboratories rose 243.20% to Rs 28.28 crore in the quarter ended March 2024 as against Rs 8.24 crore during the previous quarter ended March 2023. Sales rose 16.33% to Rs 423.07 crore in the quarter ended March 2024 as against Rs 363.69 crore during the previous quarter ended March 2023.For the full year,net profit rose 148.60% to Rs 96.16 crore in the year ended March 2024 as against Rs 38.68 crore during the previous year ended March 2023. Sales rose 19.25% to Rs 1690.43 crore in the year ended March 2024 as against Rs 1417.53 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales423.07363.69 16 1690.431417.53 19 OPM %11.444.28 -9.385.61 - PBDT51.8318.12 186 168.8983.69 102 PBT42.2011.14 279 135.4255.76 143 NP28.288.24 243 96.1638.68 149 Powered by Capital Market - Live News

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 21 May 2024Powered by Capital Market - Live News

Morepen Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 18 March 2024 .Powered by Capital Market - Live News

Net profit of Morepen Laboratories rose 255.84% to Rs 31.99 crore in the quarter ended December 2023 as against Rs 8.99 crore during the previous quarter ended December 2022. Sales rose 27.57% to Rs 444.55 crore in the quarter ended December 2023 as against Rs 348.47 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales444.55348.47 28 OPM %11.385.89 - PBDT52.4721.19 148 PBT44.0214.00 214 NP31.998.99 256 Powered by Capital Market - Live News

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 31 January 2024.Powered by Capital Market - Live News